mRNA |
Crizotinib |
CCLE |
pan-cancer |
AAC |
0.15 |
0.002 |
mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.002 |
mRNA |
SN-38 |
GDSC1000 |
pan-cancer |
AAC |
0.1 |
0.003 |
mRNA |
Doxorubicin |
gCSI |
pan-cancer |
AAC |
-0.16 |
0.003 |
mRNA |
Docetaxel |
GDSC1000 |
pan-cancer |
AAC |
0.096 |
0.003 |
mRNA |
JNJ-26854165 |
GDSC1000 |
pan-cancer |
AAC |
0.1 |
0.003 |
mRNA |
5-FU |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.004 |
mRNA |
navitoclax:MST-312 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.004 |
mRNA |
Erlotinib |
gCSI |
pan-cancer |
AAC |
0.17 |
0.004 |
mRNA |
alisertib:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.004 |